Are drug treatment strategies really effective against alopecia areata?

Transepidermal drug delivery: a new treatment option for areata alopecia?

BACKGROUND Transepidermal drug delivery (TED) is a new potential method in dermatology. Permeability alterations induced by ablative fractional resurfacing have been described with the aim to increasing the delivery of different substances into the skin. OBJECTIVE To evaluate clinical response and side effects of TED in areata alopecia (AA) treatment using ablative fractional methods associat...

Alopecia areata: Part 2: treatment.

OBJECTIVE To provide family physicians with a background understanding of the therapeutic regimens and treatment outcomes for alopecia areata (AA), as well as to help identify those patients for whom dermatologist referral might be required. SOURCES OF INFORMATION PubMed was searched for relevant articles regarding the treatment of AA. MAIN MESSAGE Alopecia areata is a form of autoimmune ha...

Alopecia areata.

n engl j med 367;3 nejm.org july 19, 2012 279 methacin should be used in addition to pancre­ atic stents in high­risk patients. However, post hoc analysis of our trial suggests that indometha­ cin may obviate the need for prophylactic pan­ creatic stent placement (unpublished data), and we therefore agree with Baron et al. that com­ parative effectiveness studies of indomethacin and pancreatic ...

Alopecia areata.

Alopecia areata is a frequent cause of hair loss. The origin of disease is not fully understood. However there are indications for a T-cell mediated autoimmune process. Genetic, immunologic and psychologic factors are important for the outbreak of disease. Most patients show localized patches of acute hair loss, where regrowth is observed spontaneously or with simple topical treatment within fe...

Alopecia Areata